Global Parkinson Disease Drug Competitive Landscape Professional Research Report 2025
Description
Global Parkinson Disease Drug Competitive Landscape Professional Research Report 2025
Research Summary
Parkinson＇s disease drugs are medications prescribed to individuals diagnosed with Parkinson＇s disease, a neurodegenerative disorder characterized by the progressive loss of dopamine-producing neurons in the brain. These drugs are primarily aimed at alleviating the motor symptoms of the condition, which include tremors, muscle rigidity, and bradykinesia (slowness of movement). The most commonly prescribed class of drugs for Parkinson＇s disease are levodopa medications, which are converted to dopamine in the brain to help replenish the deficient neurotransmitter. Other drug classes, such as dopamine agonists, MAO-B inhibitors, and COMT inhibitors, are also used to manage symptoms and extend the effectiveness of levodopa. While these drugs can provide significant relief from the motor symptoms, they do not cure Parkinson＇s disease, and their use may be tailored to each patient＇s specific needs and stage of the disease.
According to DIResearch's in-depth investigation and research, the global Parkinson Disease Drug market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Parkinson Disease Drug include Merck, GSK, Novartis, Boehringer Ingelheim, Teva Pharmaceutical, Abbvie, Kyowa Hakko Kirin Pharma, Astellas Pharma, Desitin Arzneimittel, Endo Pharmaceuticals, Roche, Bausch Health, H.Lundbeck, Supernus Pharmaceuticals, Orion, Stada Arzneimittel, Servier, Recordati, Changzhou Kangpu Pharmaceutical Co., Ltd, CSPC Pharmaceutical Group Limited, Zhejiang Jingxin Pharmaceutical Co., Ltd, Qilu Pharmaceutical, YiChang HEC ChangJiang Pharmaceutical Co., Ltd, ZEIN BIOTECHNOLOGY CO., LTD, Hunan Jiudian Pharmaceutical Co., Ltd, Luye Pharma, Shijiazhuang No.4 Pharmaceutical Co.,Ltd etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Parkinson Disease Drug. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Parkinson Disease Drug market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Parkinson Disease Drug market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Parkinson Disease Drug industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Parkinson Disease Drug Include:
Merck
GSK
Novartis
Boehringer Ingelheim
Teva Pharmaceutical
Abbvie
Kyowa Hakko Kirin Pharma
Astellas Pharma
Desitin Arzneimittel
Endo Pharmaceuticals
Roche
Bausch Health
H.Lundbeck
Supernus Pharmaceuticals
Orion
Stada Arzneimittel
Servier
Recordati
Changzhou Kangpu Pharmaceutical Co., Ltd
CSPC Pharmaceutical Group Limited
Zhejiang Jingxin Pharmaceutical Co., Ltd
Qilu Pharmaceutical
YiChang HEC ChangJiang Pharmaceutical Co., Ltd
ZEIN BIOTECHNOLOGY CO., LTD
Hunan Jiudian Pharmaceutical Co., Ltd
Luye Pharma
Shijiazhuang No.4 Pharmaceutical Co.,Ltd
Parkinson Disease Drug Product Segment Include:
Sinemet-CR
Trastal
Madopar
COMT Inhibitor
Others
Parkinson Disease Drug Product Application Include:
Under 40 Years Old
40-65 Years Old
Above 65 Years Old
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Parkinson Disease Drug Industry PESTEL Analysis
Chapter 3: Global Parkinson Disease Drug Industry Porter’s Five Forces Analysis
Chapter 4: Global Parkinson Disease Drug Major Regional Market Size and Forecast Analysis
Chapter 5: Global Parkinson Disease Drug Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Parkinson Disease Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Parkinson Disease Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Parkinson Disease Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Parkinson Disease Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Parkinson Disease Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Parkinson Disease Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Parkinson Disease Drug Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents
170 Pages
- 1 Parkinson Disease Drug Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Parkinson Disease Drug Product by Type
- 1.2.1 Sinemet-CR
- 1.2.2 Trastal
- 1.2.3 Madopar
- 1.2.4 COMT Inhibitor
- 1.2.5 Others
- 1.3 Parkinson Disease Drug Product by Application
- 1.3.1 Under 40 Years Old
- 1.3.2 40-65 Years Old
- 1.3.3 Above 65 Years Old
- 1.4 Global Parkinson Disease Drug Market Size Analysis (2020-2032)
- 1.5 Parkinson Disease Drug Market Development Status and Trends
- 1.5.1 Parkinson Disease Drug Industry Development Status Analysis
- 1.5.2 Parkinson Disease Drug Industry Development Trends Analysis
- 2 Parkinson Disease Drug Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Parkinson Disease Drug Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Parkinson Disease Drug Market Analysis by Regions
- 4.1 Parkinson Disease Drug Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Parkinson Disease Drug Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Parkinson Disease Drug Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Parkinson Disease Drug Revenue Forecast by Region (2026-2032)
- 5 Global Parkinson Disease Drug Market Size by Type and Application
- 5.1 Global Parkinson Disease Drug Market Size by Type (2020-2032)
- 5.2 Global Parkinson Disease Drug Market Size by Application (2020-2032)
- 6 North America
- 6.1 North America Parkinson Disease Drug Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Parkinson Disease Drug Market Size by Type
- 6.4 North America Parkinson Disease Drug Market Size by Application
- 6.5 North America Parkinson Disease Drug Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Parkinson Disease Drug Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Parkinson Disease Drug Market Size by Type
- 7.4 Europe Parkinson Disease Drug Market Size by Application
- 7.5 Europe Parkinson Disease Drug Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Parkinson Disease Drug Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Parkinson Disease Drug Market Size by Type
- 8.4 China Parkinson Disease Drug Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Parkinson Disease Drug Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Parkinson Disease Drug Market Size by Type
- 9.4 APAC (excl. China) Parkinson Disease Drug Market Size by Application
- 9.5 APAC (excl. China) Parkinson Disease Drug Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Parkinson Disease Drug Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Parkinson Disease Drug Market Size by Type
- 10.4 Latin America Parkinson Disease Drug Market Size by Application
- 10.5 Latin America Parkinson Disease Drug Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Parkinson Disease Drug Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Parkinson Disease Drug Market Size by Type
- 11.4 Middle East & Africa Parkinson Disease Drug Market Size by Application
- 11.5 Middle East & Africa Parkinson Disease Drug Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Parkinson Disease Drug Market Revenue by Key Manufacturers (2021-2025)
- 12.2 Parkinson Disease Drug Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Parkinson Disease Drug Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Merck
- 13.1.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Merck Parkinson Disease Drug Product Portfolio
- 13.1.3 Merck Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.2 GSK
- 13.2.1 GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 GSK Parkinson Disease Drug Product Portfolio
- 13.2.3 GSK Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.3 Novartis
- 13.3.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Novartis Parkinson Disease Drug Product Portfolio
- 13.3.3 Novartis Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.4 Boehringer Ingelheim
- 13.4.1 Boehringer Ingelheim Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Boehringer Ingelheim Parkinson Disease Drug Product Portfolio
- 13.4.3 Boehringer Ingelheim Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.5 Teva Pharmaceutical
- 13.5.1 Teva Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Teva Pharmaceutical Parkinson Disease Drug Product Portfolio
- 13.5.3 Teva Pharmaceutical Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.6 Abbvie
- 13.6.1 Abbvie Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Abbvie Parkinson Disease Drug Product Portfolio
- 13.6.3 Abbvie Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.7 Kyowa Hakko Kirin Pharma
- 13.7.1 Kyowa Hakko Kirin Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Kyowa Hakko Kirin Pharma Parkinson Disease Drug Product Portfolio
- 13.7.3 Kyowa Hakko Kirin Pharma Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.8 Astellas Pharma
- 13.8.1 Astellas Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Astellas Pharma Parkinson Disease Drug Product Portfolio
- 13.8.3 Astellas Pharma Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.9 Desitin Arzneimittel
- 13.9.1 Desitin Arzneimittel Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Desitin Arzneimittel Parkinson Disease Drug Product Portfolio
- 13.9.3 Desitin Arzneimittel Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.10 Endo Pharmaceuticals
- 13.10.1 Endo Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Endo Pharmaceuticals Parkinson Disease Drug Product Portfolio
- 13.10.3 Endo Pharmaceuticals Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.11 Roche
- 13.11.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 Roche Parkinson Disease Drug Product Portfolio
- 13.11.3 Roche Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.12 Bausch Health
- 13.12.1 Bausch Health Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.12.2 Bausch Health Parkinson Disease Drug Product Portfolio
- 13.12.3 Bausch Health Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.13 H.Lundbeck
- 13.13.1 H.Lundbeck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.13.2 H.Lundbeck Parkinson Disease Drug Product Portfolio
- 13.13.3 H.Lundbeck Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.14 Supernus Pharmaceuticals
- 13.14.1 Supernus Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.14.2 Supernus Pharmaceuticals Parkinson Disease Drug Product Portfolio
- 13.14.3 Supernus Pharmaceuticals Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.15 Orion
- 13.15.1 Orion Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.15.2 Orion Parkinson Disease Drug Product Portfolio
- 13.15.3 Orion Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.16 Stada Arzneimittel
- 13.16.1 Stada Arzneimittel Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.16.2 Stada Arzneimittel Parkinson Disease Drug Product Portfolio
- 13.16.3 Stada Arzneimittel Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.17 Servier
- 13.17.1 Servier Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.17.2 Servier Parkinson Disease Drug Product Portfolio
- 13.17.3 Servier Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.18 Recordati
- 13.18.1 Recordati Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.18.2 Recordati Parkinson Disease Drug Product Portfolio
- 13.18.3 Recordati Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.19 Changzhou Kangpu Pharmaceutical Co., Ltd
- 13.19.1 Changzhou Kangpu Pharmaceutical Co., Ltd Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.19.2 Changzhou Kangpu Pharmaceutical Co., Ltd Parkinson Disease Drug Product Portfolio
- 13.19.3 Changzhou Kangpu Pharmaceutical Co., Ltd Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.20 CSPC Pharmaceutical Group Limited
- 13.20.1 CSPC Pharmaceutical Group Limited Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.20.2 CSPC Pharmaceutical Group Limited Parkinson Disease Drug Product Portfolio
- 13.20.3 CSPC Pharmaceutical Group Limited Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.21 Zhejiang Jingxin Pharmaceutical Co., Ltd
- 13.21.1 Zhejiang Jingxin Pharmaceutical Co., Ltd Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.21.2 Zhejiang Jingxin Pharmaceutical Co., Ltd Parkinson Disease Drug Product Portfolio
- 13.21.3 Zhejiang Jingxin Pharmaceutical Co., Ltd Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.22 Qilu Pharmaceutical
- 13.22.1 Qilu Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.22.2 Qilu Pharmaceutical Parkinson Disease Drug Product Portfolio
- 13.22.3 Qilu Pharmaceutical Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.23 YiChang HEC ChangJiang Pharmaceutical Co., Ltd
- 13.23.1 YiChang HEC ChangJiang Pharmaceutical Co., Ltd Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.23.2 YiChang HEC ChangJiang Pharmaceutical Co., Ltd Parkinson Disease Drug Product Portfolio
- 13.23.3 YiChang HEC ChangJiang Pharmaceutical Co., Ltd Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.24 ZEIN BIOTECHNOLOGY CO., LTD
- 13.24.1 ZEIN BIOTECHNOLOGY CO., LTD Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.24.2 ZEIN BIOTECHNOLOGY CO., LTD Parkinson Disease Drug Product Portfolio
- 13.24.3 ZEIN BIOTECHNOLOGY CO., LTD Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.25 Hunan Jiudian Pharmaceutical Co., Ltd
- 13.25.1 Hunan Jiudian Pharmaceutical Co., Ltd Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.25.2 Hunan Jiudian Pharmaceutical Co., Ltd Parkinson Disease Drug Product Portfolio
- 13.25.3 Hunan Jiudian Pharmaceutical Co., Ltd Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.26 Luye Pharma
- 13.26.1 Luye Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.26.2 Luye Pharma Parkinson Disease Drug Product Portfolio
- 13.26.3 Luye Pharma Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.27 Shijiazhuang No.4 Pharmaceutical Co.,Ltd
- 13.27.1 Shijiazhuang No.4 Pharmaceutical Co.,Ltd Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.27.2 Shijiazhuang No.4 Pharmaceutical Co.,Ltd Parkinson Disease Drug Product Portfolio
- 13.27.3 Shijiazhuang No.4 Pharmaceutical Co.,Ltd Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Parkinson Disease Drug Industry Chain Analysis
- 14.2 Parkinson Disease Drug Industry Raw Material and Suppliers Analysis
- 14.2.1 Parkinson Disease Drug Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Parkinson Disease Drug Typical Downstream Customers
- 14.4 Parkinson Disease Drug Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
